Tamoxifen Citrate
- Product NDC
- 70518-2721
- 11-digit product format
- 705182721
- Labeler code
- 70518
- Product ID
- 70518-2721_d6e70b03-c46d-1fb3-e053-2995a90a62dd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tamoxifen Citrate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA074732
- Marketing category
- ANDA
- Marketing start
- 2020-05-01
- Marketing end
- 0000-00-00
- Substance
- TAMOXIFEN CITRATE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2721-0 | 70518272100 | 30 POUCH in 1 BOX (70518-2721-0) > 1 TABLET in 1 POUCH (70518-2721-1) | 30 pouch | 2020-05-01 | 0000-00-00 | No | No | Current |